image

The best stocks to buy since 1993

Latest issue now available

Reach - H2 looks more promising

April 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RCH
  • Price:
  • 75.5p
Reach’s FY22 results had been flagged at the January update and were no worse than that. Revenue was -2% to £601.4m and operating profit after being impacted by cost base inflation was £106.1m, with a reduced margin of 17.6% (FY21: 24%). Adjusted eps were 27.1p with a final dividend of 4.5p (ex-12 May) making 7.3p for the year. Net cash of £25.4m reflects a forward purchase of newsprint to be consumed in 2023. Chief executive Jim Mullen estimates that in 2022 it faced cumulative cost inflation from newsprint alone of over £22.5m (costs rose to £75.4m). It partly recouped this through price rises on papers but the year was also then impacted by macro pressure hitting the advertising market, which affected yields, particularly in th ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe